ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
145 hedge funds and large institutions have $1.11B invested in Alder Biopharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 65 increasing their positions, 38 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
36% less capital invested
Capital invested by funds: $1.73B → $1.11B (-$620M)
43% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 30
Holders
145
Holding in Top 10
5
Calls
$2.78M
Puts
$642K
Top Buyers
| 1 | +$18.9M | |
| 2 | +$7.66M | |
| 3 | +$6.12M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.79M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.58M |
Top Sellers
| 1 | -$32.8M | |
| 2 | -$16.6M | |
| 3 | -$9.75M | |
| 4 |
Asset Management One
Tokyo,
Japan
|
-$9.69M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$7.63M |